Cognitive Functions in Brain Tumor Patients

Hematology/Oncology Clinics of North America

Volumn 20, Issue 6, 2006, Pages 1363-1376

  Correa, Denise D ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; CYTARABINE; DEXAMETHASONE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

ACUTE BRAIN DISEASE; ATTENTION; BLOOD BRAIN BARRIER; BRAIN LYMPHOMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED RADIOTHERAPY; DEMYELINATING DISEASE; ENCEPHALITIS; GLIOBLASTOMA; GLIOMA; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; MENTAL DETERIORATION; MICROANGIOPATHY; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; SEIZURE; VERBAL MEMORY;

BRAIN NEOPLASMS; COGNITION; COGNITION DISORDERS; HUMANS; NEUROTOXICITY SYNDROMES;

EID: 33750942706     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.09.012     Document Type: Review

References (69)

1. Corry J., Smith J.G., Wirth A., et al. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol 41 (1998) 615-620
2. Meyers C.A., and Wefel J.S. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21 (2003) 3557-3558
3. Weitzner M.A., and Meyers C.A. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psycho-Oncol 6 (1997) 169-177
4. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured from brain metastases. Neurology 39 (1989) 789-796
5. Correa D.D., DeAngelis L.M., Shi W., et al. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62 (2004) 548-555
6. Dropcho E.J. Central nervous system injury by therapeutic irradiation. Neurol Clin 9 (1991) 969-988
7. Meyers C.A., and Boake C. Neurobehavioral disorders in brain tumor patients: rehabilitation strategies. Cancer Bull 45 (1993) 362-364
8. BTPRG. Report of the Brain Tumor Progress Review Group (BTPRG) (2000), National Institutes of Health, Baltimore
9. Meyers C.A., Hess K.R., Yung W.K., et al. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18 (2000) 646-650
10. Armstrong C.L., Goldstein B., Shera D., et al. The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrence. Cancer 97 (2003) 649-656
11. Meyers C.A., and Hess K.R. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro-oncol 5 (2003) 89-95
12. Klein M., Postma T.J., Taphoorn M.J.B., et al. The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology 61 (2003) 1796-1798
13. Klein M., Taphoorn M.J.B., Heimans J.J., et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19 (2001) 4037-4047
14. Klein M., Helmans J.J., Aaronson N.K., et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360 (2002) 1361-1368
15. Correa D.D., Anderson N.D., Glass A., et al. Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings. Clin Adv Hematol Oncol 1 (2003) 490
16. Tucha O., Smely C., Preier M., et al. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47 (2000) 324-334
17. Anderson S.W., Damasio H., and Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 47 (1990) 397-405
18. Hom J., and Reitan R.M. Neuropsychological correlates of rapidly vs. slowly growing intrinsic cerebral neoplasms. J Clin Neuropsychol 6 (1984) 309-324
19. Duffau H. Lessons from brain mapping in surgery for low-grade glioma: insights into association between tumour and brain plasticity. Lancet 4 (2005) 476-486
20. Lupien S.J., Gillin C.J., and Hauger R.L. Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci 113 (1999) 420-430
21. Young A.H., Sahakian B.J., Robbins T.W., et al. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacol 145 (1999) 260-266
22. Wefel J.S., Kayl A.E., and Meyers C.A. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer 90 (2004) 1691-1696
23. Sheline G., Wara W.M., and Smith V. Therapeutic irradiation and brain injury. Int J Rad Oncol Biol Physics 6 (1980) 1215-1228
24. Young D.F., Posner J.B., Chu F., et al. Rapid-course radiation therapy of cerebral metastases: results and complications. Cancer 34 (1974) 1069-1076
25. Posner J.B. Side effects of radiation therapy. In: Posner J.B. (Ed). Neurologic complications of cancer (1995), F.A. Davis, Philadelphia 311-337
26. Armstrong C.L., Corn B.W., Ruffer J.E., et al. Radiotherapeutic effects on brain function: double dissociation of memory systems. Neuropsychiatry Neuropsychol Behav Neurol 13 (2000) 101-111
27. Vigliani M.C., Sichez N., Poisson M., et al. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Rad Oncol Biol Phys 35 (1996) 527-533
28. Chak L.Y., Zatz L.M., Wasserstein P., et al. Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study. Int J Radiat Oncol Biol Phys 12 (1986) 385-389
29. Tofilon P.J., and Fike J.R. The radioresponse of the central nervous system: a dynamic process. Radiat Res 153 (2000) 357-370
30. van der Maazen R.W., Kleiboer B.J., Verhagen I., et al. Repair capacity of adult rat glial progenitor cells determined by an in vitro clonogenic assay after in vitro or in vivo fractionated irradiation. Int J Radiat Biol 63 (1993) 661-666
31. Behin A., and Delattre J.-Y. Neurologic sequelae of radiotherapy on the nervous system. In: Schiff D., and Wen P.Y. (Eds). Cancer neurology in clinical practice (2003), Humana Press Inc., Totowa, JH 173-191
32. DeAngelis L.M., Yahalom J., Thaler H.T., et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10 (1992) 635-643
33. Crossen J.R., Garwood D., Glatstein E., et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12 (1994) 627-642
34. Hochberg F.H., and Slotnick B. Neuropsychologic impairment in astrocytoma survivors. Neurology 30 (1980) 172-177
35. Imperato J.P., Paleologos N.A., and Vick N.A. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28 (1990) 818-822
36. Archibald Y.M., Lunn D., Ruttan L.A., et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80 (1994) 247-253
37. Gregor A., Cull A., Traynor E., et al. Neuropsychometric evaluation of long-term survivors of adult brain tumors: relationship with tumors and treatment parameters. Radiother Oncol 41 (1996) 55-59
38. Scheibel R.S., Meyers C.A., and Levin V.A. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 30 (1996) 61-69
39. Bradley K.A., and Mehta M.P. Management of brain metastases. Semin Oncol 31 (2004) 693-701
40. Omuro A.M., and Abrey L.E. Brain metastases. Curr Neurol Neurosci Rep 4 (2004) 205-210
41. Herman M.A., Tremont-Lukats I., Meyers C.A., et al. Neurocognitive and functional assessment of patients with brain metastases. Am J Clin Oncol 26 (2003) 273-279
42. Brouwers P., and Poplack D. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits. Am J Pediatr Hematol Oncol 12 (1990) 174-181
43. Duffey P., Chari G., Cartlidge N.E.F., et al. Progressive deterioration of intellect and motor function occurring several decades after cranial irradiation. Arch Neurol 53 (1996) 814-818
44. Salander P., Karlsson T., Bergenheim T., et al. Long-term memory deficits in patients with malignant gliomas. J Neurooncol 25 (1995) 227-238
45. Taphoorn M.J.B., and Klein M. Cognitive deficits in adult patients with brain tumours. Lancet 3 (2004) 1-18
46. Postma T.J., Klein M., Verstappen C.C.P., et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology 59 (2002) 121-123
47. Armstrong C.L., Hunter J.V., Ledakis G.E., et al. Late cognitive and radiographic changes related to radiotherapy. Neurology 59 (2002) 40-48
48. Surma-aho O., Niemela M., Vikki J., et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56 (2001) 1285-1290
49. Taphoorn M.J.B., Schiphorst A.K., Snoek F.J., et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36 (1994) 48-54
50. Laack N.N., Brown P.D., Furth A., et al. Neurocognitive function after radiotherapy (RT) for supratentorial low-grade gliomas (LGG): results of a North Central Cancer Treatment Group (NCCTG) prospective study. Int J Radiat Oncol Biol Phys 57 (2003) S134
51. Torres I.J., Mundt A.J., Sweeney P.J., et al. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 60 (2003) 1113-1118
52. Armstrong C.L., Stern C.H., and Corn B.W. Memory performance used to detect radiation effects on cognitive functioning. Appl Neuropsychol 8 (2001) 129-139
53. Correa D.D., DeAngelis L.M., Shi W., et al. Cognitive functions and APOE genotype in low grade glioma patients. Neuro-Oncology 7 (2005) 336
54. Wen P.Y. Central nervous system complications of cancer therapy. In: Schiff D., and Wen P.Y. (Eds). Cancer neurology in clinical practice (2003), Humana Press, Totowa NJ 215-231
55. Meyers C.A. Neurocognitive dysfunction in cancer patients. Oncology 14 (2000) 75-78
56. Postma T.J., van Groeningen C.J., Witjies R.J., et al. Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma. J Neurooncol 38 (1998) 69-75
57. Shapiro W.R., Chernik N.L., and Posner J.B. Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neuro 28 (1973) 96-102
58. DeAngelis L.M., and Shapiro W.R. Drug/radiation interactions and central nervous system injury. In: Gutin P.H., Leibel S.A., and Sheline G.E. (Eds). Radiation injury to the nervous system (1991), Raven Press, New York 361-382
59. Keime-Guibert F., Napolitano M., and Delattre J.Y. Neurological complications of radiotherapy and chemotherapy. J Neurol 245 (1998) 695-708
60. Abrey L.E., DeAngelis L.M., and Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 16 (1998) 859-863
61. Neuwelt E.A., Goldamn D.A., Dahlborg S.A., et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9 (1991) 1580-1590
62. Crossen J.R., Goldman D.L., Dahlborg S.A., et al. Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. Neurosurgery 30 (1992) 23-29
63. Dahlborg S.A., Henner W.D., Crossen J.R., et al. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 2 (1996) 166-174
64. Dalhborg S.A., Petrillo A., Crossen J.R., et al. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery. Cancer J Sci Am 4 (1998) 110-124
65. Roman-Goldstein S.M., Mitchell P., Crossen J.R., et al. MR and cognitive testing of patients undergoing osmotic blood-brain barrier disruption with intraarterial chemotherapy. Am J Neuroradiol 16 (1995) 543-553
66. McAllister L.D., Doolittle N.D., Guastadisegni P.E., et al. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46 (2000) 51-61
67. Fliessbach K., Helmstaedter C., Urbach H., et al. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 64 (2005) 1184-1188
68. Schlegel U., Pels H., Glasmacher A., et al. Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatry 71 (2001) 118-122
69. Harder H., Holtel H., Bromberg J.E.C., et al. Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62 (2004) 544-547